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ABSTRACT
POSITIONS IN THE GLUN2C-CONTAINING NMDAR REGULATE
ALCOHOL SENSITIVITY AND ION CHANNEL GATING
MAN WU
Marquette University, 2014

The N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate-gated ion
channel, has been shown to be a major target of ethanol in the central nervous
system (CNS). Previous studies have identified positions in the third and fourth
membrane-associated (M) domains of the NMDAR GluN1 and GluN2A
subunits that influence ethanol sensitivity. Among the alcohol sensitive sites, a
methionine residue is highly conserved in all GluN1 and GluN2 subunits. We
proposed the methionine position (Met-821) in the M4 domain of the GluN2C
subunit can regulate ethanol sensitivity and ion channel gating.
14 mutations were made at the methionine position, 7 substitutions yielded
functional receptors, which can influence ethanol sensitivity, glutamate potency
and desensitization compared to wild type NMDAR containing GluN2C subunit.
The other 7 mutations showed small spontaneous currents with apparent
ethanol inhibition.
The predicted structure of the NMDAR indicates that alcohol sensitive positions
in the M3-M4 intersubunit interfaces between the two subunit types interactively
regulate ethanol sensitivity and ion channel gating. We proposed that the Met821 position interact with the Gly-638 or Phe-639 position in the GluN1 M3
domain to regulate ethanol sensitivity and ion channel gating. Dual tryptophan
mutants G638W/M821W and F639W/M821W showed small spontaneous
currents with apparent ethanol inhibition. To test the interaction between these
two pairs of positions, cysteine mutations were made at Gly-638, Phe-639, and
Met-821. Dual cysteine mutants G638C/M821C and F639C/M821C yielded
functional receptors. G638C/M821C showed significant interaction with respect
to ethanol inhibition, suggesting these pair of positions interactively regulate
ethanol sensitivity and ion channel gating.

DTT reducing experiments showed DTT-potentiated currents and increased
deactivation time constant Tau in the dual cysteine mutant G638C/M821C.
In the present studies, we showed that the Met-821 position involved in
regulating ethanol sensitivity and ion channel gating. We also showed Gly-638
and Met-821 positions in the M3-M4 intersubunit interfaces between GluN1 and
GluN2C subunits interactively regulate ethanol sensitivity. The results we
observed from GluN2C-containing NMDAR are different from the previous
discoveries in the NMDAR containing GluN2A subunit. The difference may
mainly lies in the sequence difference between GluN2A and GluN2C M4
domains and small hydrophobic environment formed near the methionine
position.
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Chapter 1. Introduction

The NMDA receptor: a general introduction
The N-methyl-D-aspartate (NMDA) receptor, belonging to the ionotropic
glutamate receptor family, is highly expressed in the central nervous system
(CNS)[2, 3]. The NMDARs are sensitive to the specific agonist N-methyl-Daspartate (NMDA)[4, 5], which distinguishes NMDARs from other L-glutamateactivated receptors (AMPA, kainite, and delta)[6]. As one of the most important
neurotransmitter-activated ion channels in the brain, NMDAR plays critical roles
in multiple aspects of brain function, including generating rhythms for breathing
and locomotion activities, controlling synaptic plasticity underlying learning and
memory processes, and regulating higher cognitive brain functions, such as
cognition, attention, and fear[7-10].

NMDA receptor development and distribution
NMDARs are heterotetramers[1, 11-13], and functional receptors are
assembled from two GluN1 subunits with either two GluN2 subunits or a
combination of GluN2 and GluN3 subunits[14-16]. The GluN1 subunit, as the
key element of tetrameric NMDARs, is present and widespread from an early
developmental stage[17-19]. In contrast, GluN2 subunits show distinct
expression patterns during the developmental process. In the rat CNS, only

2

GluN2B and GluN2D subunits are expressed during the prenatal stage, but
shortly after birth, GluN2A and GluN2C subunits quickly predominate while the
GluN2B and GluN2D subunits decline to adult levels, resulting in a limited
distribution[20]. GluN2B expression levels peak in the hippocampus and cortex
during the third postnatal week and then decline to the low adult levels, while
GluN2A expression continues to increase in the hippocampus and cortex, and
peak throughout the brain during the third postnatal week before declining to
adult levels[21-24]. GluN2C expression is very low in the cerebellum and
forebrain at P7, but dramatically increases in the cerebellum at P12, where its
expression peaks throughout granule cells during the third postnatal week and
where it continuous to be expressed at high levels in the adult as the
predominant subunit[23, 25]. In summary, the GluN1 and GluN2A subunits are
ubiquitous in the adult brain; the GluN2B subunit is mainly in the forebrain; the
GluN2C subunit predominates in the cerebellum and various select nuclei; and
the GluN2D subunit is limited to the diencephalon and the midbrain[20, 25-28].

NMDA receptor physiology
The NMDARs are integral membrane proteins formed by four subunits, at least
two GluN1 subunits with either two GluN2 subunits or a combination of GluN2
and GluN3 subunits[14-16]. Each individual subunit contains four distinct
domains: the extracellular amino-terminal domain (ATD), which is involved in
subunit assembly, trafficking and modulation; the ligand-binding domain (LBD),
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which participates in agonist or competitive antagonist binding and channel
activation; the membrane-associated domains (MD), which form the
membrane-spanning part of the receptor, and an intracellular carboxyl-terminal
domain (CTD), which is mainly responsible for receptor localization and
signaling regulation. Although each GluN subunit shares highly homologous
sequence and architecture, NMDAR kinetics, regulation, and interaction with
multiple intracellular proteins varies depending upon subunit composition[28,
29]. First, at resting membrane potentials, most subtypes of NMDARs undergo
rapid channel block by extracellular Mg2+, which is only relieved with
simultaneous depolarization and synaptic release of glutamate[30-32].
GluN2C–containing NMDARs are ~ 10 fold less sensitive to Mg2+ block
compared to receptors containing GluN2A and GluN2B NMDARs[14, 33].
Second, NMDARs are highly permeable to both monovalent cations and Ca2+
ions. NMDAR activation results in an influx of Ca2+ as well as the influx of Na+
and efflux of K+[34-37]. Ca2+ entry has been demonstrated to be the key trigger
for many important physiological activities including long-term potentiation (LTP)
[7, 38, 39]and long-term depression (LTD)[40-42], where the relative magnitude
of the rise in intracellular Ca2+ concentration and its temporal and spatial
character determines which type of synaptic plasticity is induced[43-46]. Third,
NMDAR activation requires coincident binding of both glutamate and the coagonist glycine[47, 48]. Glutamate is the endogenous agonist of GluN2
subunits[49, 50], while glycine and D-serine act as the agonist at the GluN1
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subunit[51, 52]. In addition to glutamate, D- and L-aspartate are also
endogenous agonists for the GluN2 subunits[53-56]. The GluN2 subunits show
various glutamate potencies and efficacies. The GluN2A and GluN2B subunits
have lower potency compared to the GluN2C and GluN2D subunits[14, 57, 58],
but higher efficacy as indicated by higher open probability (Po) during the time
when the receptor is fully occupied by agonist (intraburst Po). Fourth, NMDAR
desensitization is defined as a reduced response in the sustained presence of
agonist. There are at least three different processes of NMDAR apparent
desensitization: true desensitization, in which NMDAR responses are
diminished in the continued presence of glutamate in a time-dependent
manner[28, 59]; glycine-dependent apparent desensitization, in which binding
of glutamate decreases the affinity for glycine, so that NMDAR responses
decay in the presence of low concentrations of glycine[60, 61]; calcium
inactivation, in which intracellular Ca2+ causes a decay in NMDAR-mediated
current through an interaction with the GluN1 subunit cytoplasmic domain[6163]. All forms of apparent and real desensitization are prominent in GluN2Acontaining NMDARs, but are not observable in GluN2C-containing NMDARs[14,
64-66]. Fifth, NMDAR deactivation contributes to the EPSC time course and is
also dependent on subunit composition. The time constants of deactivation in
NMDARs containing GluN2C or GluN2D subunits are much higher than those
in GluN2A- and GluN2B- containing NMDARs.

5

The NMDA receptor pharmacology
The complicated architecture of the NMDAR provides agonists and antagonists
with several distinct binding sites. The glycine binding site in the GluN1 subunit
ligand-binding domain (LBD) is activated by glycine or D-serine, and blocked
by antagonists such as 7-chlorokynurenic acid and its analog 5,7dichlorokynurenic acid (5,7-DCKA)[67-69]. Glutamate, NMDA, aspartate, and
other agonists activate the glutamate binding site in GluN2 subunits and the
classical

competitive

antagonists

of

this

site

are

(R)-2-amino-5-

phosphonopentanoate (AP5 or APV)and its analogs, such as AP7[47].
Extracellular Mg2+ blocks the NMDAR channel pore at negative membrane
potentials. Other open channel blockers, such as MK-801 and ketamine, block
the ion channel in a manner that is not voltage-dependent, although recovery
from block is accelerated by the outward movement of ions at positive
membrane potentials[70]. Zinc inhibits NMDAR via dual actions: at millimolar
concentrations, it produces ion channel block[71], and at nanomolar
concentrations, it binds to the GluN2A ATD[72-74] of GluN2A-containing
NMDAR to cause a rapid decay in current[75, 76]. Polyamines such as
spermine and spermidine can inhibit or potentiate the NDMARs activities, at
high and low concentrations respectively. At low micromolar concentrations,
polyamines promote channel opening and at high concentrations, they block
the channel[77-79].
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The NMDA receptor and alcohol addiction
Ethanol is one of the most widely abused drugs in the world. Chronic alcohol
exposure can cause multiple aspects of changes in brain morphology, function
and behavior. Studies have shown that alcohol addiction not only can cause
brain shrinkage and loss of neurons, but is associated with aberrant learning
and memory processes[80-83]. It acts on multiple target proteins in the central
nervous system at high millimolar concentrations[2, 3]. Among those targets,
the NMDARs play a crucial role for the inhibitory effect of ethanol in the
brain[84-90]. One of the earliest studies from Lovinger et al (1989). showed that
acute ethanol exposure can inhibit NMDA-activated current in hippocampal
neurons[91]. Later, ethanol inhibition of NMDA receptor activity was also
demonstrated by measuring NMDA receptor-mediated excitatory postsynaptic
potentials/currents (EPSPs/EPSCs) in slices from many different brain regions,
such

as

cortex[92,

93],

amygdala[94],

nucleus

accumbens[95,

96],

hippocampus[91], and dorsal striatum[97, 98]. Similar inhibitory effects of
ethanol were also found in HEK cells and Xenopus oocytes, expressing
recombinant NMDA receptors. Single-channel recordings provided evidence
that ethanol decreases the open channel probability and mean open time of
NMDA receptors in cultured cortical neurons[92]. Although all of this evidence
indicates that ethanol rapidly inhibits NMDA receptor function in vivo and in vitro,
the precise molecular mechanisms of ethanol inhibition on the NMDA receptors
have been difficult to determine. By using electrophysiological techniques,
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rapidly-inhibited NMDA-evoked currents were detected in response to acute
ethanol exposure in a concentration-dependent manner[99, 100], which
suggested ethanol directly interacts with NMDA receptors. The questions that
remain concern where this small molecule binds in NMDA receptors and how it
changes NMDA receptor channel kinetics.

Based on the evidence that alcohol and NMDARs antagonists produce similar
inhibitory effects in vivo and in vitro, studies mainly focused on finding alcohol
molecule binding sites in the agonist site or other modulatory sites. However,
the effect of ethanol on NMDARs of cultured mouse hippocampal neurons only
showed decreased Emax values of the NMDARs concentration-response curve
without affecting EC50 values, which indicates that ethanol inhibit NMDARs
activity in a non-competitive manner[86, 99, 101-103]. Whether the co-agonist
(glycine) site can mediate ethanol’s effects was initially controversial[86, 102107]. Wright et al. (1996) showed that ethanol inhibition of NMDA channels
does not involve substantial changes in fast closed state kinetics or changes in
open channel conductance, and thus is not attributable to block of the open
channel[92]. Peoples et al. (1997) showed there is no effect on ethanol
inhibition of NMDA-activated currents even in the presence of different
concentrations of Mg2+ in the cultured cortical neurons[103]. These two
evidence indicate that alcohol molecule binding sites are not in the channel
pore. Taken together, there is no evidence that alcohol binding sites are in the
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extracellular structure of the NMDARs and suggests ethanol may affect
NMDARs activities via effects on lipids or other intracellular proteins, such as
protein kinase C (PKC). Snell et al. (1994) demonstrated the involvement of
PKC in ethanol-induced inhibition of NMDARs in cerebellar granule cells[108].
In contrast, Peoples and Stewart (2002) showed C-terminal truncation mutant
did not abolish the effect of ethanol on the NMDARs[99]. This result against the
possibility that the alcohol inhibition on NMDARs is mediated via intracellular
part of the receptors. Results from mutagenesis studies with alcohol- and
anesthetic-sensitive γ-aminobutyric acid A (GABAA) and glycine receptors
showed that mutation at a serine residue in the second transmembrane (TM2)
domain or an alanine residue in the third transmembrane (TM3) domain greatly
affected the potentiation of GABAA and glycine channel function by ethanol and
volatile anesthetics[109]. Larger amino acids in the ethanol sensitive positions
produce inhibition, while smaller amino acids producing enhanced potentiation.
To find the alcohol action sites in the membrane-associated domain, Peoples
and Woodward groups started a series of scanning studies in the M domain.
Our lab first identified Met-823, a site of alcohol action in the M4 domain of the
GluN2A subunit, which can not only alter ethanol sensitivity of GluN2Acontaining

NMDAR,

but

can

regulate

glutamate

potency,

apparent

desensitization, mean open time, and peak current density[110, 111]. The
Woodward lab found Phe-639, a site in the M3 domain of the GluN1 subunit,
which also can alter ethanol sensitivity[112]. Above evidence confirmed the
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hypothesis that alcohol molecule can act on the sites in the membraneassociated domains. In the following studies, a series of ethanol sensitive
resides are recognized in both GluN1 and GluN2A subunit, Gly-638 in the M3
domain of the GluN1 subunit, the cognate positions Phe-636, Phe-637, Met823, Ala825 in GluN2A subunit[110, 111, 113-115] (Figure 1). Taken together,
these ethanol sensitive sites are hydrophobic amino acids; are not involved in
lining the ion channel lumen; and influence ion channel gating properties.

Because alcohol molecule can act on multiple sites in NMDARs, it is likely that
ethanol sensitive residues form a small environment to regulate ethanol
sensitivity together. Dual mutations at Phe-637 and Met823 in GluN2A subunit
can influence ethanol sensitivity and receptor kinetics, which suggests that
these two positions are functionally linked because modulation of ethanol by
dual mutants is not additive[116]. Based on the reported structure of the GluA2
glutamate receptor M domains[1], it is possible that sites of alcohol action is
formed by groups of 4-6 residues clustered in small regions at the M3-M4
intersubunit interfaces between GluN1 and GluN2A subunit[114] (Figure 1). By
using two-way ANOVA and mutant cycle analysis of log-transformed ethanol
IC50 values, significant interactions affecting ethanol inhibition was observed
at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824,
Met-818/Phe-636, and Leu-819/Phe-637[114]. Unlike the interaction between
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Phe637 and Met823 in GluN2A subunit, these sites can alter ethanol action in
a manner that all side chains of interacted residues are in close proximity[114].

Although accumulated evidence showed the important role of GluN1 and
GluN2A subunit in the action of alcohol, it is largely unknown how other GluN2
subunits are involved in the modulation. The protein sequence of M3 and M4
domains is highly conserved through all GluN subunits. So, it is likely that
GluN2C subunit also contain alcohol sensitive sites in the M3 and M4 domains.
Unlike GluN2A and GluN2B subunit, GluN2C subunit has a limited distribution
in cerebellum[20, 25-27]. The GluN2C subunit also can be found in
thalamus[25], olfactory bulb[25], oligodendrocytes[117], and hippocampal
interneurons[20]. The GluN2C subunit has its unique electrophysiologic and
pharmacologic properties that differ from those of the GluN2A and GluN2B
subunits. For example, the GluN2C-containing NMDA receptor has a lower
open probability, being opens for only ~1% of the time during agonist
activation[64], a lower single-channel conductance, shorter open time, lower
sensitivity to Mg2+ block[20, 118], and higher affinity for the agonist and
coagonist glutamate and glycine[57, 119]. In vivo studies have shown that
GluN2C knockout mice have significant deficits in working memory and
acquisition of conditioned fear[120], suggesting that GluN2C plays an important
role in controlling cerebellum function. The GluN2C-containing NMDA receptor
also shows differences in alcohol sensitivity. GluN2C-containing NMDA
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receptors are less sensitive to ethanol compared to GluN2A- and GluN2Bcontaining NMDA receptors[121-123]. To fill the gap and better understand the
function of GluN2C subunit, we will focus on studying the molecular mechanism
of alcohol modulation of GluN2C-containing NMDAR.
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Chapter 2. Material and Methods

Materials
Ethanol (95%, prepared from grain) will be obtained from Aaper Alcohol &
Chemical Co. (Shelbyville, KY), and all other drugs will be obtained from Sigma.
Chemicals used to make recording solutions were the highest purity available.

Molecular Biology, Cell Culture, and Transfection
Site-directed mutagenesis in plasmids containing GluN1 or GluN2C subunit
cDNA was performed using the QuikChange II kit (Agilent Technologies, Santa
Clara,

CA),

and

all

mutants

were

verified

by

double-strand

DNA

sequencing. TSA201 cells, a transformed human kidney 293 cell line, were
maintained in flasks containing serum supplemented Dulbecco’s minimum
Eagle medium in a humidified 5% CO2 incubator. For recordings, cells were
plated onto fibronectin-coated 35mm dishes at high-density (approximately 5 ×
105 cells per dish) and transfected with GluN1, GluN2C, and green fluorescent
protein (GFP) using the calcium phosphate transfection kit (Invitrogen). 10mM
magnesium chloride (MgCl2) was added to the culture medium to prevent
excitotoxic cell death. MgCl2 was removed before use in experiments by
extensive washing. Cells were used in experiments 24-48h after transfection.
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Electrophysiological Recording
Whole-cell patch-clamp recording was performed at room temperature using
an Axon 200B amplifier (Molecular Devices, Sunnyvale, CA). Patch pipettes
(1–3 MΩ) were pulled from borosilicate glass and filled with internal solution
containing 140 mM CsCl, 2 mM Mg4ATP, 10 mM BAPTA, and 10 mM HEPES
(pH 7.2). The recording solution containing 150 mm NaCl, 5 mmKCl, 0.2
mm CaCl2, 10 mm HEPES, 10 mm glucose, and 10 mm sucrose. The ratio of
added HEPES-free acid and sodium salt was calculated to result in a solution
pH of 7.4 (Buffer Calculator, R. Beynon, University of Liverpool). Solutions of
agonists and ethanol were prepared fresh daily and applied to cells using a
stepper motor-driven rapid solution exchange apparatus (Warner Instruments,
Inc.) and 600-μm inner diameter square glass tubing. In concentrationresponse experiments, the order of application of the various concentrations of
ethanol was randomized for each cell to eliminate time-dependent effects. Data
were filtered at 2 kHz (8-pole Bessel) and acquired at 5 kHz on a computer
using a DigiData interface and pClamp software (Axon Instruments).

Cysteine Cross-linking
Wild type and cysteine-substituted mutant receptors were treated with the
reducing agent 10mM DTT for 3-5min. In the presence of 300 μM glutamate,
steady-state currents were measured. The effect of DTT was calculated by the
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equation [((Iafter/Iinitial) − 1) × 100], where Iinitial and Iafter are the stabilized current
before and DTT treatment.

Molecular Modeling
The model of the MD of the heteromeric GluN1/GluN2C NMDAR was
generated using the GluA2 (PDB-3KG2) as a template[1]. We first manually
aligned the GluN1 and GluN2C sequences with the respective sequences of
GluA2 as described in Supplemental Fig2. [1] in Discovery Studio 2.5 (Accelrys,
San Diego, CA). Then we mutated Gly-638, Phe-639 and M821 into cysteines.

Data Analysis
In concentration-response experiments, IC50 or EC50 and n (slope factor) were
calculated using the equation y = Emax/1 + (IC50 or EC50/x)n, where y is the
measured current amplitude, x is concentration, n is the slope factor,
and Emax is the maximal current amplitude. Statistical differences among
concentration-response curves were determined by comparing log transformed
IC50 or EC50 values from fits to data obtained from individual cells using oneway analysis of variance (ANOVA) followed by the Dunnett test.

Time constant (τ) of deactivation were determined from fits of the current decay
after the removal of glutamate (in the continued presence of glycine) to an
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exponential function using Clampfit (Axon Instruments/Molecular Devices).
Cells were adequately fitted by a single exponential function.

Significant interactions respect to ethanol sensitivity, steady state current and
deactivation among mutants were determined by two-way ANOVA and by
mutant cycle analysis[124]. Natural logarithm (ln) transformed values of WT and
mutant IC50 or EC50 or time constant (τ) values were used for computing
interaction free energies by using the equation ΔΔGINT = RT[ln(WT) +
ln(mut1,mut2) − ln(mut1) − ln(mut2)], with propagated errors reported in
standard error (SEM). ΔΔGINT ± error were analyzed using one-sample t test
for statistical significance from zero energy, with degrees of freedom (df) =
NWT + NMUT1+ NMUT2 + NMUT1,MUT2 − 4, where NX = number of cells used for each
combination of wild-type and mutant subunits.
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Chapter 3. A Methionine (Met-821) Position in the M4 Domain of GluN2C

Subunit Can Alter Ethanol Sensitivity.

Introduction
Alcohol, one of the oldest and most widely abused drugs in the world, produces
its effects primarily via actions on ion channels in the nervous system. The Nmethyl-D-aspartate (NMDA) receptor, a subtype of ionotropic glutamate
receptor family, has been demonstrated to be a major target in mediating the
inhibitory effects of alcohols in the mammalian brain. Chronic ethanol exposure
can result in up-regulation of NMDA receptor function and enhanced glutamatemediated excitotoxicity[125-128]. The Lovinger and colleagues first showed
that acute ethanol exposure can inhibit NMDA-activated currents in
hippocampal neurons. In the following studies, ethanol inhibition on NMDARs
activities also has been demonstrated by measuring NMDARs-mediated
excitatory postsynaptic potentials/currents (EPSPs/EPSCs) in various slices
from many different brain regions, such as cortex[92, 93], amygdala[94],
nucleus accumbens[95, 96], hippocampus[91], and dorsal striatum[97, 98].
Similar inhibitory effects of ethanol were also observed in cell lines, like HEK293
cells, expressing recombinant NMDARs. In single-channel studies, mean open
time and frequency of channel opening are decreased in the presence of
ethanol[92].
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The NMDAR is heterotetramer, composed of two GluN1 subunits with either
two GluN2 subunits or a combination of GluN2 and GluN3 subunits[14-16]. The
GluN2 subunit contains four subtypes (A-D) that arise from separate genes,
whereas the GluN1 subunit has eight isoforms that are generated by alternative
splicing of a single gene[129]. The subunit compositions affects the
physiological and pharmacological properties of the NMDARs[8]. All 32
combinations of GluN1/GluN2 subunits have been examined in the presence
of 100mM ethanol. Generally, receptors containing GluN2A and GluN2B
subunits are more sensitive to ethanol inhibition than receptors containing
GluN2C and GluN2D subunits[47], suggesting subunit composition can
influence ethanol sensitivity.

Because ethanol and NMDARs antagonists produce similar inhibitory effects
on receptor activities in vivo and in vitro, an initial question was whether ethanol
was a NMDAR antagonist binding in the agonist binding site. However, a
number of studies showed the effect of ethanol only decreased Emax values of
the concentration-response curve without affecting EC50 values which indicates
that ethanol inhibit NMDARs activity in a non-competitive manner[86, 99, 101103]. Peoples et al. (1996) showed ethanol inhibition on NMDARs did not
involve substantial changes in fast closed state kinetics, changes in open
channel conductance, or block of the open channel[92] and there was no effect
on ethanol inhibition of NMDA-activated currents even in the presence of
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different concentrations of Mg2+ in cultured cortical neurons[103], which
indicates that alcohol molecule binding sites are not in the channel pore. Taken
together, there is no evidence that alcohol binding sites are in the extracellular
structure of the NMDARs and suggests ethanol may affect NMDARs activities
via effects on lipids or other intracellular proteins, such as protein kinase C
(PKC). Snell et al. (1994) demonstrated the involvement of PKC in ethanolinduced inhibition of NMDARs in cerebellar granule cells[108]. In contrast,
Peoples and Stewart (2002) showed C-terminal truncation mutant did not
abolish the effect of ethanol on the NMDARs[99]. This result argues against the
possibility that the alcohol inhibition on NMDARs is mediated via intracellular
part of the receptors.

Results from mutagenesis studies with alcohol- and anesthetic-sensitive γaminobutyric acid A (GABAA) and glycine receptors showed that mutation at a
serine residue in the second transmembrane (TM2) domain or an alanine
residue in the third transmembrane (TM3) domain greatly affected the
potentiation of GABAA and glycine channel function by ethanol and volatile
anesthetics[109]. Larger amino acids in the ethanol sensitive positions produce
inhibition, while smaller amino acids producing enhanced potentiation.
Although the sequence and structural homology between GABAA and glycine
and glutamate receptors are extremely low, it is likely that ethanol sensitive
sites exist in the M domains of the NMDARs.
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The membrane-associated domains (MD) of the NMDARs are composed of
four segments, including M1, M3, M4 spanning the membrane[130-133] and
M2 forming a reentrant loop[134]. Using the substituted cysteine accessibility
method (SCAM)[135], cysteine substitution mutants were generated to identify
channel-lining residues of the GluN1 subunit[136]. Within the M1 segment, all
nine consecutive positions (W545-H553) were not accessible to the cysteinespecific methanethiosulfonate (MTS) reagents in the presence of glutamate, in
contrast the preM1 segment, defined as the segment further N-terminal to the
M1 segment, were accessible to both MTS-ethylammonium (MTSEA) and the
larger MTS-ethyltrimethylammonium (MTSET). These reagents can covalently
link their positively charged -S-CH2-CH2-NH3+ or -S-CH2-CH2-N(CH3)3+ groups
to the sulfhydryl groups of cysteines exposed to the water-accessible surface
of the channel[134]. The overall pattern of accessibility for MTSEA and MTSET
suggests that positions in preM1, but not in M1 itself, are exposed at the wateraccessible surface of the extracellular vestibule[136]. The SCAM results also
shows that the regions C-terminal to M3 and N-terminal to M4 are also the
primary determinants of the extracellular vestibule[136]. The residues in the M3
and M4 domains are mainly involved in channel-lining.

The Woodward group first examined whether positions in the M domains alter
ethanol sensitivity. Alanine substitutions at several residues within the preM1,
M1, and M2 domains did not produce significant changes in ethanol sensitivity.
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In contrast, alanine mutation at GluN1 (Phe-639)/GluN2A yielded significantly
less sensitive to ethanol than wild type[137]. Tryptophan substitution at this
position produces slightly more sensitivity to ethanol inhibition than wild type.
These results may suggest that the physical or chemical properties of the amino
acid substitution at this position may be an important determinant of ethanol
sensitivity[137]. The Phe-639 residue is highly conserved through all GluN1 and
GluN2 subunits, suggesting a key role for this residue. Coexpressing either
GluN1 (F639A)/GluN2B or GluN1 (F639A)/GluN2C also produce significantly
less sensitivity, which is consistent with the results observed from mutant
combination GluN1 (F639A)/GluN2A[137]. Although the F639A mutation
significantly reduced ethanol sensitivity of all mutant combinations NDMARs, it
did not fully eliminate ethanol inhibition, indicating there may be other ethanol
sensitive sites or the cognate sites in the GluN2 subunits also play a critical role
in altering ethanol sensitivity.

Based on the assumption that additional site or sites of alcohol action in one of
the M domains exists, we used tryptophan scanning mutagenesis and found a
highly conserved methionine residue in the M4 domain of GluN2A subunit can
influence NMDARs alcohol sensitivity in a manner that is related both to
desensitization of the ion channel and the physical and chemical properties of
the substituent amino acid[111]. GluN2A(M823C), GluN2A(M823S), and
GluN2A(M823W) produced the lowest sensitivity to ethanol, whereas
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GluN2A(M823F), GluN2A(M823L), and GluN2A(M823Y) resulted in the highest
sensitivity to ethanol[111]. In the studies of alcohol action of GABAA and glycine
receptors, it has been shown that the physical and chemical properties of
substituent amino acid play a determinant role of ethanol sensitivity. Linear
regression analysis of alcohol sensitivity versus hydropathy, hydrophilicity,
hydrogen bonding, molecular volume, and polarity of the substituent was
performed and significant linear relationships were observed between ethanol
IC50 and both hydrophilicity and molecular volume[111].

It should be noted that either GluN1 (Phe-639) or GluN2A (Met-823) are not
able to completely eliminate the inhibitory effects of alcohol, which indicates
alcohol molecule acts on multiple sites of the NMDARs. In the following studies
of scanning ethanol sensitive sites, a series positions of alcohol action are
identified in both GluN1 and GluN2A subunit, Gly-638 in the M3 domain of the
GluN1 subunit, the cognate positions Phe-636, Phe-637, Met-823, Ala825 in
GluN2A subunit[110, 111, 113-115]. Taken together, these ethanol sensitive
sites are hydrophobic amino acid; are not involved in lining the ion channel
lumen; influence ion channel gating properties.

In previous studies of the role of GluN1 (Phe-639) in alcohol sensitivity
modulation, similar significant reduced ethanol sensitivity were observed
among the different GluN2 subunit containing NMDARs[137]. Although
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GluN2C-containing NMDAR is much less sensitivity to ethanol compared to
GluN2A- and GluN2B-containing NDMARs, the mutant combination GluN1
(Phe-639)/GluN2C is still markedly less than its wild type[137]. The methionine
residue is highly conserved among all GluN2 subunits and has been shown to
play a critical role in alcohol action modulation in GluN2A-containing
NMDAR[111]. So, it is likely this methionine residue can influence ethanol
sensitivity in the GluN2C-containing NMDAR. Figure 2 shows the model of the
GluN2C subunit with the membrane-associated domains (M1-M4), and the
presumed location of Met-821 residue in the M4 domain of GluN2C subunit.

Results

Ethanol Inhibition by Various GluN2 Subunits at the Methionine Residue

in M4.
According to the previous studies in this laboratory, a methionine residue in M4
domain of the GluN2A subunit not only regulates ethanol sensitivity, but
influences ion channel gating[110, 111]. To determine whether the effects of
the methionine residue on ethanol sensitivity are consistent through the GluN2
subunits, GluN2A (M823W), GluN2B (M824W), and GluN2C (M821W) were
coexpressed with GluN1 subunit. Surprisingly, ethanol sensitivity of GluN2
subunits with tryptophan substitution at the methionine residue exhibited
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differently that determined for their respective wild type counterparts (Figure 3).
As reported previously, GluN2A (M823W) showed significantly decreased
ethanol sensitivity[111]; in contrast, GluN2C (M821W) showed significantly
increased ethanol sensitivity. There was no significant difference between wild
type GluN2B and GluN2B (M824W). The slope factors of the ethanol
concentration-response curves did not differ significantly among the subunits.

Mutations at Met-821 Can Alter Ethanol Sensitivity and Glutamate

Activation.
Since the GluN2C (Met-821) position involved in altering ethanol sensitivity, we
made 14 mutations at the methionine position to determine how this position
regulates ethanol sensitivity. There were 7 mutations yielded functional
receptors and were tested inhibited by ethanol in a concentration-dependent
manner. Ethanol IC50 values among the mutants varied ranging from 138 to 215
mM (ANOVA, p < 0.0001).The slope factors of the ethanol concentrationresponse curves did not differ significantly among the various mutants.
Expression of the mutant subunits GluN2C (M821L), GluN2C (M821S),
GluN2C (M821W) with GluN1 subunits resulted in the highest sensitivity to
ethanol. Tryptophan, the largest and most hydrophobic amino acid,
unsurprisingly produced the greatest effect of alcohol action on the receptor
with ethanol IC50 value of 138 mM. Alanine, the smallest hydrophobic amino
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acid that is unlikely to destabilize α-helical regions, is predicted to eliminate or
diminish hydrophobic interactions present between larger side chains. However,
GluN2C (M821A) did not alter ethanol sensitivity(Figure 4).

Surprisingly, a number of amino acid substitutions at this site yielded
nonfunctional receptors. M821D, M821F, M821G, M821N, M821R, M821V,
M821Y exhibited abnormal ion channel function. The abnormal functional
mutants exhibited small spontaneous currents with apparent ethanol inhibition.
This is the first time in this laboratory we observed ion channel behavior like
these mutants(Figure 4).

Ethanol Sensitivity is Independent of the Physical and Chemical

Properties of the Substituent at GluN2C (Met-821).
In the previous study showing that GluN2A (M823W) can alter ethanol
sensitivity of the GluN2A-containing NMDAR, a linear relation was observed
between ethanol IC50 and hydrophilicity (R2 = 0.522; p < 0.05) and molecular
volume (R2 = 0.683; p < 0.005) of the substituent[111]. If the observed changes
in ethanol sensitivity among the GluN2C (Met-821) mutant subunits were due
to a direct interaction of ethanol with this site, a significant linear relation of
ethanol IC50 with the physical and chemical properties of the amino acid
substituent at this site is expected. To evaluate the relative contribution of the
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physicochemical parameters of the amino acid at this site to alcohol sensitivity,
linear regression analysis of ethanol IC50 values versus hydropathy,
hydrophilicity, molecular volume and polarity of the substituent were
performed[111]. There was no significant linear relation observed between
ethanol IC50 values and hydropathy (R2 = 0.007; p > 0.05), hydrophilicity (R2 =
0.09; p > 0.05), molecular volume (R2 = 0.205; p > 0.05), or polarity (R2 =
0.047; p > 0.05) (Figure 5). Although we did not detect any correlation, we
observed a positive trend between ethanol IC50 values and hydrophilicity, and
a negative trend between ethanol IC50 values and molecular volume, which
may due to missing plots. There were seven mutations that showed abnormal
glutamate activation.

Triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR Can Restore Ion

Channel Gating Function.
Mutations at the methionine residue yielded abnormal functional mutants,
including M821D, M821F, M821G, M821N, M821R, M821V, M821Y. It is likely
that the Po of these mutants may be too low for detecting glutamate-activated
currents. So, we coexpressed GluN1, GluN2A, GluN2C subunits to form
triheteromeric NMDARs, in which GluN2A subunit increases the Po of the
receptors and stabilize the conformation to induce channel gating. Because
GluN2A subunit is supposed to contain a high affinity Zn2+ binding site in the
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ATD[138], whereas GluN2C subunit does not, diheteromeric GluN1/GluN2A
NMDAR is highly sensitivity to Zn2+ modulation. 200nm Zn2+ is sufficient to
cause

almost

100%

inhibition

on

the

diheteromeric

GluN1/GluN2A

NMDAR[139]. Triheteromeric GluN1/GluN2A/GluN2C NMDAR restores half
sensitivity to nanomolar Zn2+ modulation[139]. We observed similar effects that
200 Zn2+ inhibited almost all diheteromeric GluN1/GluN2A NMDAR and
diheteromeric GluN1/GluN2C, GluN1/GluN2C M821G NMDARs was not
sensitive to nanomolar concentration Zn2+ inhibition and triheteromeric
GluN1/GluN2A/GluN2C NMDAR restores half sensitivity to Zn2+. We then
coexpressed triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR, which
yielded functional receptor and Zn2+ produced half inhibition on the
triheteromeric

receptor(Figure

6).

The

functional

triheteromeric

GluN1/GluN2A/GluN2C M821G NMDAR seems to restore agonist sensitivity
because a GluN2A subunit may induce receptor gating by inducing activation
of the GluN2C (M821G) subunit.

Discussion
The results of the present study demonstrate that mutations at the highly
conserved methionine (Met-821) in the M4 domain of the GluN2C subunit can
influence ethanol sensitivity of the GluN2C-containing NMDAR. As expected,
the largest amino acid tryptophan produces largest change in the ethanol IC50
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values compared to wild type. In contrast, an alanine mutation at this position
did not yield any significant change of ethanol sensitivity. These results are not
in agreement with the hypothesis that alanine would alter ethanol sensitivity by
eliminating or diminishing hydrophobic interactions present between larger side
chains. We also observed a number of amino acid substitutions at this site
yielding abnormal functional receptors, which did not exhibit glutamateactivated currents, but showed apparent ethanol inhibition in the presence of
both glutamate and ethanol. Although it has been reported in the GluN2A (Met823) paper that several nonfunctional receptors were yielded when methionine
was replaced by other amino acid[111], this is the first observation that the
channel did not open properly, but still responded to the inhibitory effects of
ethanol.

Although diheteromeric GluN1/GluN2C (M821G) has abnormal function,
triheteromeric GluN1/GluN2A/GluN2C (M821G) restored ion channel gating
function. GluN2C-containing NMDAR has an extremely low open probability
(Po~1%)[64], and a lower single-channel conductance of approximately
35pS[20, 118]. In contrast, NMDAR containing GluN2A subunit has a 50-fold
greater

open

probability

(Po~50%)

compared

to

GluN2C-containing

NMDAR[140]. The subunit-specific gating of NMDARs is controlled by the
region formed by the ATD of the GluN2 subunit[140]. Moreover, single-channel
analysis from mutations at GluN2A (M823) showed the substitutions at this

28

position can alter ion channel gating[110]. Taken together, it is likely that
abnormal functional mutants have an extremely low open probability, which
resulted in negligible glutamate-activated currents, but the coincidently opened
channel still responded to ethanol and exhibited ethanol inhibition of these
currents. Triheteromeric GluN1/GluN2A/GluN2C (M821G) NMDAR containing
an ATD from the GluN2A subunit increases open probability and induces the
channel to gate properly.

The functional mutations at Met-821 residue all produced glutamate-activated
currents and ethanol-inhibited currents. The ethanol IC50 values among the
mutants are all different: M821L, M821S, and M821W mutants produced the
highest sensitivity to ethanol. Taken together with our previous studies in
GluN2A[111], this suggests that some physical or chemical properties of the
amino acid substitution at this position may be an important determinant of
ethanol sensitivity[109]. We thus expected a significant linear relation of ethanol
IC50 with the physical and chemical properties of the amino acid substituent at
this site. However, the results showed no correlation between ethanol IC50
values and any physicochemical parameters of the amino acid, suggesting
ethanol sensitivity is not simply represented by physical and chemical
properties of the substituent at GluN2C (Met-821).
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It has been reported that alcohols and anesthetics bind to the sites between M2
and M3 domains of GABAA and glycine receptors and regulate channel function
in a molecular volume dependent manner[109, 141-143]. Our lab reported a
similar volume occupation effect at GluN2A (Met-823): a significant linear
relation of ethanol sensitivity with molecular volume was observed when the
value for the tryptophan mutant was excluded from the analysis[111]. All the
evidence above suggested that the action of alcohol molecule involves filling a
critical volume in a cavity formed in part by this site and the presence of a
tryptophan, with the largest side chain, severely disrupts normal channel
function and ethanol inhibition[111]. However, in the case of the GluN2C
subunit, the increased ethanol sensitivity of the tryptophan mutant at Met-821
is in agreement with the volume occupation theory, and suggests that
tryptophan does not disrupt channel function or the ability to interact with the
alcohol molecule.

In the study of GluN1(Phe639), it has been shown that F639W can alter ethanol
sensitivity in a non GluN2 subunit dependent way such that any GluN2 subunit
coexpressed with GluN1(F639W) showed reduced inhibitory effects of 100 mM
ethanol compared to their respective wild type counterparts[137]. Although like
the phenylalanine residue, the methionine residue in the M4 domain is highly
conserved through all GluN2 subunits, comparison between wild type and
tryptophan mutants among GluN2 subunits showed that the methionine
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position regulates ethanol sensitivity in a GluN2 subunit dependent manner.
GluN2A (M823W) showed significantly decreased ethanol sensitivity, whereas
GluN2C (M821W) significantly increased ethanol sensitivity, and there was no
significant difference in ethanol sensitivity between the wild type GluN2B and
GluN2B (M824W). These results are consistent with our previous evidence that
alcohol action involves multiple adjacent residues that form a small environment
to regulate ethanol sensitivity together[114]. In addition to the Met-823 residue,
our lab found a phenylalanine residue in the M3 domain of the GluN2A subunit,
the cognate site of GluN1 (Phe-639).

Dual mutations at Phe-637 and Met823

in GluN2A subunit can influence ethanol sensitivity and receptor kinetics, which
suggests that these two positions are functionally linked because modulation of
ethanol by dual mutants is not additive[116]. Functional interactions not only
occur between the residues within M3 and M4 domains in the same subunit,
but direct interactions can also be observed between residues in the M3 and
M4 domains from different subunits. By using two-way ANOVA and mutant
cycle analysis of log-transformed ethanol IC50 values, significant interactions
affecting ethanol inhibition were observed between multiple intersubunit M3/M4
domain pairs, including GluN1 (G638W)/GluN2A(M823W) [114]. Unlike the
interaction between Phe637 and Met823 in the GluN2A subunit, the side chains
of these interacting residues are in close proximity[114].
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Considering the important role of GluN2C (Met-821) in regulation of alcohol
action, we studied its role in altering ion channel gating and its possible
interactions with other residues to affect ethanol sensitivity in the following
studies.
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Chapter 4. A Methionine In the M4 Domain of the GluN2C Subunit Can

Alter Ion Channel Gating.

Introduction
Ionotropic glutamate receptors, including NMDA, AMPA, kainate, and delta
receptors, are integral membrane proteins composed of four large subunits,
which form a central ion channel pore. High similarity in sequence alignment
among the ionotropic glutamate receptors family suggests that these receptors
share a similar architecture. A glutamate receptor subunit contains four discrete
semiautonomous domains: the amino-terminal domain (ATD), the ligandbinding domain (LBD), the membrane-associated domain (MD), and the
carboxyl-terminal domain (CTD)[1].

The ATDs share sequence homology and structurally similarities with the
LBD[1]. To study the function of the ATDs, numerous mutant subunits have
been constructed including those lacking the entire ATD[73, 144-151].
Truncations in the ATD do not affect receptor assembly, and there are
functional similarities between the truncated mutants and wild type receptor,
suggesting a nonessential, regulatory role of the ATD for core function[10].
Evidence that the ATD can influence open probability, deactivation,
desensitization, and subunit-specific assembly is consistent with regulatory
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roles of the ATD[72, 140, 152-155]. Moreover, the ATD also harbors binding
sites for divalent cations, such as Zn2+[72], and subunit-selective negative
allosteric modulators, such as ifenprodil[156]. The ATD has a clamshell-like
structure, composed of two lobes-R1 and R2, tethered together by loops[150].
Binding of Zn2+ to GluN2A or ifenprodil to GluN2B subunits seems to stabilize
a closed-cleft conformation of the ATD[150].

The LBD also has a clamshell-like architecture containing two lobes-S1 and S2,
which are structurally similar to the ATD[157]. The S1 was identified by the
region of extracellular N-terminal domain preceding the PreM1 domain, and S2
is the loop between the M3 and M4 domains[157-160]. Between the S1 and S2
segment, there is an agonist binding pocket[1, 161, 162]. The activation of
glutamate receptors involves simultaneous binding of agonists, such as
glutamate, NMDA, and the coagonists, such as glycine or D-serine, to the
GluN2 and GluN1 subunits, which leads to conformational change to enclose
the agonists in the binding sites[157, 161, 163]. This conformational event
triggers the subsequent transition of the channel pore into an open state[10,
164, 165]. In the open state, both the LBD and MD are in an unstabilized state,
and stability can be restored by LBD reopening to allow agonist dissociation[10,
164, 165]. In the agonist-bound state, the LBD dimer interface will go through
a rearrangement, allowing the receptor to enter a desensitized state[166-168].
Other forms of apparent NMDAR desensitization are related to glycine[60, 61]
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or intracellular Ca2+[61-63], and real or apparent ion channel desensitization
can influence the amplitude, duration, and following frequency of NMDAmediated synaptic events[61].

The MD is connected to the LBD by three short peptide linkers[1]. The MD of
the NMDARs is composed of four segments, M1, M3, and M4 which span the
membrane[130-133] and M2 which forms a reentrant loop[134]. The
transmembrane helices M2 and M3 from each of the four subunits contribute to
formation of the channel pore. In the previous chapter, we have discussed
SCAM results of the MD. According to the cysteine substitution channel-lining
experiments, the overall pattern of accessibility for MTSEA and MTSET
suggests that preM1, but not M1 itself, are exposed at the water-accessible
surface of the extracellular vestibule and the regions C-terminal to M3 and Nterminal to M4 are also the primary determinants of the extracellular
vestibule[136].

Unlike other domains, the CTD is the most diverse one, varying in sequence
and length among the glutamate receptor family[10]. The CTD mainly involves
in regulatory effects on receptor localization and function. The CTD of GluN1
subunit contains a number of regulatory protein binding sites, including sites for
Ca2+/calmodulin[169], scaffold proteins as well as phosphorylation sites for
protein kinase A (PKA), and protein kinase C (PKC)[170, 171].
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Although the functional role of each structural element in the entire subunit has
been well characterized, the nature of the conformational changes and
molecular determinants underlying NMDARs are still largely unknown.
Numerous evidence shows that the LBD is structurally and functionally linked
to the MD. The dynamics between these two structural elements can affect
each other reciprocally. From the early work on GluN1 (F639W), it is known that
this position not only alters alcohol action of the NMDARs, but affects channel
properties, such as glycine potency. The increased affinity for glycine but not
glutamate[137] is consistent with the evidence that GluN1 subunit contains
glycine binding site, whereas GluN2 subunits provide glutamate binding sites[1].
Our previous work on GluN2A (M823W) showed that mutation at the
methionine position only altered the steady state glutamate EC50 values,
instead of glycine EC50 values[110]. Taken together, sites in the MD also can
influence ion channel gating and may be involved in transducing agonist binding
into ion channel gating[110, 172, 173]. Mutations at MD not only affect agonist
potencies, but receptor kinetics, such as mean open time (MOT), deactivation,
and desensitization. GluN2A (M823W) mutant receptors have dramatically
altered apparent desensitization, and increased mean open time[110]. GluN2A
(F637W) and (F636W) mutant receptors also show alterations in glutamate
potency, desensitization and MOT.

36

Results

Effects of mutations at GluN2C (Met-821) on glutamate potency and

desensitization.
According to previous work on the cognate site GluN2A (Met-823), mutations
at this position not only affected alcohol action of the receptors, but
physiological characteristics, such as glutamate potency and desensitization.
To test whether the GluN2C (Met-821) residue can also affect glutamate
sensitivity

and

desensitization,

we

performed

concentration-response

experiments for glutamate in the functional mutants using a rapid solution
exchange apparatus in lifted cells. For the functional mutants, significant
differences were obtained in the EC50 values for glutamate-activated
peak (P<0.001; ANOVA) and steady-state (P<0.001; ANOVA) current and for
the steady-state to peak current ratio (Iss:Ip; P<0.0001; ANOVA). The EC50
values for glutamate-activated peak current were altered among the majority of
functional mutants, but the EC50 values for steady-state current were changed
only in the M821I, M821L, and M821S mutants. Surprisingly, the tryptophan
mutant only had a difference in the peak EC50 value, but not steady-state EC50
value. The slope factors of the glutamate concentration-response curves for
both peak and steady-state did not differ significantly from the wild type values
in any of the mutants. Apparent desensitization was affected by most of the
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mutations, even when steady-state EC50 values were unchanged. It also should
be noted that there was no observable desensitization in the wild type GluN2C
subunit(Figure 7).

In the previous studies, we reported that a linear correlation was obtained
between either peak EC50 values versus steady-state EC50 values or
peak/steady-state EC50 values versus the steady-state to peak current ratio
(Iss:Ip)[110, 113]. However, we did not obtain any kind of correlation (Figure 8).

Effects of GluN2C (Met-821) Mutants on Deactivation.
One of the prominent features of glutamate receptors in gating kinetics are time
course of deactivation, which mediate a majority of excitatory synaptic
transmission. One unique physiological property of GluN2-containing NMDAR
is unusually prolonged deactivation time course following the removal of
glutamate. To measure the maximal response, the co-agonist glycine was
present in all solutions (50μM), which saturated all the glycine binding sites,
and current responses were evoked with 300μM glutamate. GluN2C-containing
NMDAR deactivated slowly with a single exponential time course with time
constants ranging from 1098 to 2183 ms (Figure 9). We subsequently analyzed
time constants of deactivation for other mutants at the Met-821 position. There
was a significant difference among the mutants compared to wild type
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(P<0.0001; ANOVA). M821L, M821T, M821W mutants have the most
significant changes for the deactivation. It should be noted that the steady-state
EC50 value of tryptophan mutant does not have difference compared to wild
type receptor, while deactivation time course of this mutant becomes faster than
wild type.

Discussion
The results of the present study demonstrate that alcohol sensitive position
Met-821 in the M4 domain of the GluN2C subunit is involved in regulating ion
channel gating and receptor kinetics. The tryptophan mutant can alter
glutamate-activated peak current, but not steady-state current EC50 values. The
steady-state to peak current ratio (Iss:Ip) also changed because of the attribution
of the significantly increased peak EC50 values. We performed linear regression
analysis between either peak EC50 values versus steady-state EC50 values or
peak/steady-state EC50 values versus the steady-state to peak current ratio,
and found that there was no correlation between any of these pharmacological
parameters. In the studies of cognate site GluN2A (Met-823), we reported that
steady-state EC50 values were highly correlated with steady-state to peak
current ratio, which was interpreted as agonist trapping on desensitized
receptors causing increased affinity[110]. The present studies of GluN2C (Met823) showed that a majority of mutations at these position significantly increase
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the peak EC50 values without affecting the steady-state EC50 values. In contrast,
mutations at GluN2A (Met-823) only affected steady-state EC50 values instead
of peak EC50 values[110]. Taken together, the underlying mechanism at Met821 appears to differ from the trapping mechanism observed at GluN2A (Met823).

GluN2C-containing NMDAR deactivated slowly with a single exponential time
course with time constants ranging from 1098 to 2183 ms, which is
approximately 40-fold longer compared to receptors containing GluN2A[66,
174] . The deactivation tau of the M821W mutant 1291±160 ms, is significantly
different from wild-type and other mutants at this position. Several lines of
investigation have identified there are several factors that can regulate
deactivation time constant of NMDARs, such as the rates of ligand association
and dissociation, which are the primary determinants of the deactivation time
course[10]. We have showed that dual tryptophan mutant combinations GluN1
(L819W)/GluN2A (F637W) can significantly interact with each other to alter
deactivation[114]. The observations in this study provide additional evidence
that mutations at MD also can affect time course of deactivation.
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Chapter 5. A Methionine (Met-821) Position in the M4 Domain of GluN2C

Subunit Can Interact with Positions in the M3 Domains of GluN1 Subunit.

Introduction
Ethanol is one of the common drugs of abuse and acts at high concentrations
(millimolar) on multiple targets in the central nervous system to regulate
neuronal activities[2, 3]. Among those are mainly channels gated by the
neurotransmitter glutamate, the major excitatory neurotransmitter in the
mammalian brain. The N-methyl-D-aspartate (NMDA) receptors, subtypes
belonging to the glutamate receptor family, play the most crucial role for the
inhibitory effect of ethanol[84, 85]. The first evidence that ethanol inhibited
NMDAR evoked currents in hippocampal neurons was shown by Lovinger et al.
(1989)[91]. Subsequent studies using radiolabeled neurotransmitter release,
calcium uptake, and ratiometric calcium indicators confirmed that NMDARs are
inhibited by alcohol across a wide range of brain regions[175]. Although there
is numerous studies leading to the conclusion that ethanol inhibits NMDAR
function, the mechanism of alcohol action remains unclear. The inhibitory effect
of alcohol action on NMDA-evoked currents is in a voltage-independent manner
and is not involved in altering single channel conductance, suggesting that
alcohol molecule does not act as an ion channel pore blocker[92, 176]. There
is also evidence showing that ethanol inhibition is not relate to competitive
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inhibition at the glycine and glutamate binding sites[86, 101, 103, 107, 123], or
allosteric modulation[103, 121]. In addition, although the phosphorylation sites
in the CTD, in some instances, modulate ethanol sensitivity of the NMDARs[95,
175, 177], receptors lacking the CTD still show sensitivity to ethanol[99].

Ronald et al. first found a phenylalanine residue (Phe-639) in the M3 domain of
the GluN1 subunit influences alcohol sensitivity[137]. The previous studies from
our laboratory also identified a number of alcohol sensitive sites, including two
phenylalanine residues (Phe-636) and (Phe-637) in the M3 domain of the
GluN2A subunit[113, 115], a methionine residue (Met-823) and an alanine
residue (Ala-825) in the M4 domain of the GluN2A subunit[111, 114]. Although
these residues can alter ethanol sensitivity of NMDARs, mutations at these
sites did not abolish ethanol inhibition. Studies in GABAA and glycine receptors
showed residues in transmembrane domains two and three forming sites of
alcohol and anesthetic action[109, 178]. Based on these results, we tested the
role of dual tryptophan mutants GluN2A (F637W M23W) in influencing ethanol
sensitivity and receptor function. We observed that dual mutations at Phe-637
and Met823 in GluN2A subunit can interactively influence ethanol sensitivity
and receptor kinetics, which suggests that these two positions are functionally
linked because modulation of ethanol by dual mutants is not additive[116]. After
this study was performed, the high-resolution structure of an ionotropic
glutamate receptor was reported [1]. Our group subsequently showed that sites
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of alcohol action are formed by groups of 4-6 residues clustered in small regions
at the M3-M4 intersubunit interfaces between GluN1 and GluN2A subunit[114].
By using two-way ANOVA and mutant cycle analysis of log-transformed ethanol
IC50 values, significant interactions affecting ethanol inhibition were observed
at four pairs of positions in GluN1/GluN2A: Gly-638/Met-823, Phe-639/Leu-824,
Met-818/Phe-636, and Leu-819/Phe-637[114] (Figure 1). Unlike the functional
interaction between Phe637 and Met823 in GluN2A subunit, these side chains
appear to physically interact with one another, which is consistent with the
proposed model that places these pairs of positions in close proximity [114].

Unlike GluN2A-containing NMDAR, which predominates in mammalian brain
and has been shown to be involved in multiple brain functions, GluN2Ccontaining NMDAR are mainly expressed in cerebellar granule neurons[20, 2527], thalamus[25], olfactory bulb[25], oligodendrocytes[117], and hippocampal
interneurons[20]. The GluN2C subunit has unique electrophysiological and
pharmacologic properties that differ from those of the GluN2A subunit. For
example, the GluN2C-contianing NMDA receptor has a lower open probability,
being open for only ~1% of the time during agonist activation[64], a lower singlechannel conductance, shorter open time[20, 118], higher affinity for the agonist
and coagonist glutamate and glycine[57, 119], and much less sensitivity to
ethanol compared to GluN2A-containing NMDAR[121-123]. To understand the
role of GluN2C subunit in regulating ethanol sensitivity and channel gating
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function, the cognate position Met-821 in the M4 domain was substituted by
tryptophan and showed different alcohol sensitivity, glutamate potency and
desensitization. Dual tryptophan mutants GluN1 (G638W)/ GluN2C (M821W)
and GluN1 (F639W)/ GluN2C (M821W) showed abnormal channel gating
activity in the presence of glutamate, which may suggest apparent interactions
between these two pairs of positions at the intersubunit interface in the M3 and
M4 domains of the GluN1 and GluN2C subunits. In this study we introduced
cysteine mutations in the GluN1 at G638, F639 and in the GluN2C at M821.
Significant changes in ethanol sensitivity, agonist affinity, and deactivation have
been observed and mutant cycle analysis also showed an interaction between
the dual cysteine mutants. Based on these findings, we propose that two pairs
of positions can interact and play a crucial role for ethanol sensitivity modulation
and channel gating activity.

Results

Effects of Dual Tryptophan Mutants on Glutamate Activation.
Our previous studies have identified significant interactions altering ethanol
sensitivity between the GluN1 (G638) and GluN2A (M823) positions[114]. We
predicted that the cognate sites in GluN2C-containing NMDAR M3-M4
intersubunit interfaces would exhibit a similar interaction consistent with a site
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of alcohol action. Using tryptophan substitution, we first tested whether single
tryptophan mutants at GluN1 (G638), GluN1 (F639), GluN2C (M821) could alter
ethanol sensitivity. Tryptophan is the largest amino acid and has consistently
produced the greatest effect on ion channel behavior in previous studies from
this laboratory[110, 111, 113-115]. All of the single tryptophan mutants
exhibited increased alcohol sensitivity, in which the ethanol IC50 value was
significantly decreased (p <0.0001; ANOVA) (Figure 10). We next coexpressed
either GluN1 (G638W) or GluN1 (F639W) with GluN2C (M821W), which is
predicted to be in close proximity. However, neither G638W/M821W nor
F639W/M821W exhibited observable glutamate-activated currents.

Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and

GluN2C Subunits Interact to Regulate Ethanol Inhibition.
The GluN1 (G638W)/GluN2C (M821W) GluN1 (F639W)/GluN2C (M821W) dual
tryptophan mutants were not sensitive to glutamate, but both mutants appeared
to respond to ethanol, in that very small apparent spontaneous currents in these
mutants were inhibited by 100mM ethanol. These may be due to the side chain
of tryptophan at one position, which may interact with the side chain of the other
one to disrupt the ion channel gating activity. To test whether the sites in the
M3 and M4 domains intersubunit interfaces can interact, we made cysteine
substitution at G638, F639 and M821 positions. All of the single cysteine
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mutants did not alter ethanol sensitivity, but ethanol IC50 value in the mutant
combination G638C/M821C differed significantly from the wild type (p < 0.0001;
ANOVA) (Figure 11). Interestingly, we observed the opposite results in the
mutations F639C/C744A and F639C/C744A/M821C, in which the redox site
Cys744 is substituted by alanine, decreased ethanol sensitivity. We next used
both two-way analysis of variance (ANOVA) on log-transformed IC50 values and
mutant cycle analysis to calculate whether there were significant free energy
changes. We found an interaction between the mutant combinations of
G638C/M821C and G638C/C744A/M821C, as both types of analysis were
statistically significant. In contrast, we did not detect any interaction in
F639C/M821C, but in F639C/C744A/M821C (Figure 12).

Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and

GluN2C Subunits Can Regulate Glutamate Potency.
To determine whether dual cysteine mutants also influence glutamate potency,
we compared EC50 values for glutamate activation of steady-state currents.
Both single cysteine mutants GluN1 (F639C) and GluN2C (M821C) showed
different glutamate EC50 values and highly significant differences were obtained
in dual cysteine mutants F639C/C744A/M821C (p < 0.0001; ANOVA) (Figure
13). Interestingly, although G638C/M821C exhibited significantly altered IC50
value, it was not involved in changing steady-state glutamate potency;

46

F639C/M821C did not change ethanol sensitivity, but varied the agonist affinity.
After removing the redox site Cys744, we observed both dual cysteine mutants
G638C/C744A/M821C

and

F639C/C744A/M821C

significantly

altered

glutamate EC50 values.

Coexpressed Cysteine Mutants in the M3 and M4 Domains of GluN1 and

GluN2C Subunits Can Regulate NMDA Receptor Kinetics.
Our previous results have shown that dual tryptophan mutants GluN1
(G638W)/GluN2A (M823W) can interact to alter NMDA receptor kinetics[114].
If the side chain of cysteine at G638 or F639 in the GluN1 M3 domains interact
with the side chain of cysteine at M821 in the GluN2C M4 domains and are
involved in regulating ion channel function, dual cysteine mutants should also
affect relevant ion channel behaviors. We measured time of decay among the
mutants: the cysteine mutants containing redox site Cys744 all showed
markedly decreased time constant of deactivation compared to wild type, while
the mutants with C744A all increased the time of decay. We observed
extremely prolonged deactivation in the mutant GluN1 (F639CC744A)/GluN2C
(Figure 14). Then, we analyzed interactions among the dual cysteine mutants
respect to deactivation. In the group containing redox site C744, although time
constants of deactivation differed among the various mutants, we did not
observed significant interactions with respect to deactivation between
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G638C/M821C and F639C/M821C; while in the group with C744A, significant
interaction was obtained in the mutant combination F639C/C744A/M821C
(Figure 15).

Cross-linking Between Cysteine Substitutions in the M3 and M4 Domains

of GluN1 and GluN2C Subunits.
To confirm whether G638/F639 and M821 are sufficiently spatially proximal to
interact, we examined the effects of applying the reducing reagent DTT among
the mutants. Previous work from other laboratories has reported that a pair of
cysteine residues, Cys744 and Cys798 in GluN1, is responsible for the
potentiation of GluN1/GluN2A by DTT, and that redox modulation can be
completely abolished in the mutant GluN1 (C744A, C798A)/GluN2C[179-181].
To eliminate the effect of endogenous redox sites, we substituted cysteine at
C744 with alanine. However, we did not observe DTT-potentiated currents in
either GluN1/GluN2C or GluN1(C744A)/GluN2C. We then examined the effects
of DTT on all the single and dual cysteine mutations. As expected, significant
potentiation was only obtained among dual cysteine mutants. There was no
effect of DTT treatment on current amplitude in any single cysteine mutant. In
contrast, when either the GluN1 (G638C) or GluN1 (F639C) mutants (with or
without the C744A mutation) were expressed with GluN2C (M821C), DTT
treatment significantly increased current amplitudes (Figure 16). We also
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compared time constants of deactivation after DTT exposure among the
mutants, and observed significant increases in time constants of decay in dual
cysteine mutants containing the Cys744 residue, but not in those containing
C744A (Figure 17).

Discussion
These experiments were aimed at determining whether residues in GluN1 M3
and GluN2C M4 at the intersubunit interfaces interact to alter ethanol sensitivity
and NMDA receptor ion channel behavior. We have observed that single
tryptophan substitutions at GluN1 (G638), GluN1 (F639), or GluN2C (M821)
can alter ethanol IC50 values, but neither GluN1 (G638W)/GluN2C (M821W)
nor GluN1 (F639W)/GluN2C (M821W) receptors exhibit glutamate-activated
current. However, both dual tryptophan mutants exhibit small-amplitude
spontaneous currents that respond to ethanol. Apparent ethanol inhibition has
been observed between these two mutants. These results are mostly in
agreement with the results from our previous findings[114] and suggest
apparent interaction between G638W/M821W or F639W/M821W may be too
strong to disrupt NMDA receptor function. Based on the x-ray crystallographic
structure of the GluA2 subunit[1] and the structural model of the NMDAR M
domains[114], we predict these two pairs of residues are in close proximity to
produce effects on ethanol sensitivity and NMDA receptor function.
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Our previous work demonstrated that the side chains of one amino acid can
interact with one another to alter ethanol sensitivity[114]. In this study, we made
cysteine mutations at the above positions to determine the effects of amino acid
side chain interaction. Using both two-way ANOVA and mutant cycle analysis,
significant interaction was observed between GluN1 (G638C)/GluN2C (M821C),
which is consistent with our previous results[114]. Redox site modulation
experiments also demonstrated that a disulfide-bond is spontaneously formed
between these two positions that alters current amplitude, and that the disulfide
bond can be reduced by DTT to enhance glutamate-activated currents.
Although this study does not directly answer the question about which
coexpressed tryptophan mutations at GluN1 (G638)/GluN2C (M821) interacts
to alter ethanol sensitivity and NMDA receptor function, we have demonstrated
that the side chain of one cysteine can interact with one another in mediating
the action of alcohol. These results are consistent with our previous findings in
GluN1 (G638W)/GluN2A (M823W)[114].

NMDARs are regulated by an extracellular redox state and both GluN1 and
GluN2 subunits are involved in redox modulation. Two disulfide bonds have
been found within GluN1 subunit, including Cys744 and Cys798 in the LBD and
SVC79ED and RGC308VG in the ATD[179, 181]; Cys87 and Cys320 are
proposed to form a disulfide bond within the ATD of GluN2A subunit[150]. The
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disulfide bonds formed within the ATD are responsible for the modification of
the Zn2+ binding site[179], so in the present study, we only considered the
endogenous redox site Cys744 and Cys798 and mutated the cysteine at C744
residue into alanine. In the study of ethanol inhibition, we found that only the
dual cysteine mutant G638C/M821C altered ethanol sensitivity, as this mutant
had decreased ethanol IC50 values, whereas in the group with C744A, GluN1
(F639C/C744A) exhibited extremely low ethanol sensitivity and the dual
cysteine mutation F639C/C744A/M821C also significantly decreased ethanol
sensitivity. When we removed GluN1 (F639C/C744A)/GluN2C from the
analysis group, a significant difference was obtained in the dual cysteine mutant
GluN1 (G638C/C744A)/GluN2C (M821C). Although the involvement of Cys744
altered ethanol sensitivity among the mutants, the trend of change is similar in
the group with or without C774A. Because the Cys744 is in the LBD, the change
in this position may alter agonist affinity. In the glutamate concentrationresponse experiments, GluN1 (Cys-744)/GluN2C significantly decreased
steady-state glutamate EC50 values compared to wild type GluN2C-containing
NMDAR. The cysteine mutants containing C744A all showed decreased
glutamate EC50 values except the dual cysteine mutant G638C/C744A/M821C.
Time of decay also showed that mutants containing C744A increased Tau
values, which is consistent with the increased agonist affinity. Taken together,
the cysteine mutants containing C744A alter ethanol sensitivity in an additive
manner. The alcohol molecule acts on the membrane-associated domain
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instead of the LBD as an antagonist[86, 99, 101-103, 111], so it is likely that the
mutation at Cys744 causes a long distance effect on the conformational change
of the MD to affect ethanol sensitivity. We have demonstrated that the change
in the methionine position in the GluN2A subunit can cause agonist trapping in
the LBD to alter ethanol sensitivity[110, 111], the change in the LBD may
subsequently affect the alcohol action in the MD. In this study we used both
mutant cycle analysis and two-way analysis of variance to test for interactions
among dual cysteine mutants. Ethanol IC50 values may represent fewer kinetic
rates compared with steady-state glutamate EC50 values. It has been
demonstrated that the main action of ethanol on NMDAR kinetics is to decrease
mean open time[92], whereas glutamate EC50 depends on both agonist
binding and ion channel gating[114, 182]. Alcohol action in the mutants
containing C744A may involve multiple kinetic rates, so we only analyzed the
interaction among the dual cysteine mutants containing Cys744. A significant
interaction with respect to ethanol sensitivity was obtained in the mutant
combination G638C/M821C, but not in the mutant F639C/M821C.

The redox site modulation by reducing reagent DTT showed potentiated
currents in all the dual cysteine mutants. The time constant of decay after DTT
treatment was significantly increased in dual cysteine mutants containing
Cys744. Breaking disulfide bonds between two pairs of cysteine residues in the
GluN1 M3 and GluN2C M4 domain intersubunit interface can regulate receptor
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kinetics. We showed that mutations at GluN2A (Met-823) can affect agonist
affinity by trapping the agonist in the closed, desensitized state[110]. Although
apparent desensitization was not changed by these mutations, these mutations
are in domains involved in regulating gating and we obtained a significant
interaction between G638C/M821C with respect to ethanol sensitivity. However,
we did not detect a significant interaction with respect to deactivation in either
G638C/M821C or F639C/M821C. The interaction we observed between the
GluN1 M3 and GluN2C M4 domains cysteine residues may mainly alter the
local conformational change, which is only reflected in a change in ethanol
sensitivity.

In summary, taking the results of this study together with those of previous
studies, we predict an interaction between G638C/M821C involved in
regulating ethanol action on NMDAR(Figure 18). It will be of interest in future
studies to test how adjacent amino acid side chains contribute to alter alcohol
action and ion channel gating within the M3-M4 interfaces.
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Chapter 6. General Discussion
We found that the GluN2C (Met-821) is an alcohol sensitive residue, which is
also responsible for regulating ion channel gating. It is possible that observed
changes in ethanol sensitivity among the mutants at the methionine position
result from changes in agonist potency or ion channel gating kinetics. Plotting
ethanol IC50 values against both peak and steady-state glutamate EC50 values
revealed there is no correlation. A significant linear relation was obtained when
ethanol IC50 was plotted versus maximal Iss:Ip values (R2 = 0.501; P < 0.05)
(Figure 19).

In the study of GluN2A (Met-823), we found that ethanol IC50 was negatively
correlated with the maximal Iss:Ip values, such that the greater the
desensitization in a given mutant, the lower its ethanol sensitivity[111]. It is
possible that GluN2A (Met-823) influences ethanol sensitivity indirectly via
changes in desensitization. In contrast, we observed a positive linear relation
between ethanol sensitivity and apparent desensitization among the various
mutants at GluN2C (Met-821). Ethanol has been shown to influence
desensitization in several ligand-gated ion channels, including α-amino-3hydroxy-5-methyl-4-isoxazolepropionic

acid

receptor

(AMPA)[183],

5-

hydroxytryptamine (5-HT), and GABA receptors[184]. The opposite effects of
mutations at GluN2C (Met-821), and its cognate position GluN2A (Met-823) on
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ethanol sensitivity and desensitization may suggest that ethanol inhibition of
NMDARs does not involve changes in desensitization.
Although mutants at GluN2C (Met-821) can alter glutamate EC50 values, we did
not detect any correlation between ethanol sensitivity and glutamate potency.
Most mutants showed significantly increased peak glutamate EC50 values, but
not steady-state glutamate EC50 values. It is possible that the alcohol molecule
physically interacts with the M821 position and leads to the limited
conformational changes only in the MD, which will not affect the conformation
of the LBD. Unlike the trapping theory we observed in GluN2A (Met-823), the
changes in the GluN2C (Met-821) position only cause short distance changes,
which only alter the local environment.

Although highly homologous sequences are found among all the GluN2
subunits, several different amino acids are found in the M4 domain between
GluN2A and GluN2C subunit (Figure 20). There is only one different residue in
the M3 domain between GluN2A and GluN2C subunit, and it is located at the
C-terminal end of the M3 domain. It is unlikely there is either a physical or
functional interaction between that position and the sites in the M4 domain
because of the very long distance. We then compared the amino acids near the
methionine residue between GluN2A and GluN2C subunit. We found that the
Ala-825 and Ala-826, which are downstream of the GluN2A (Met-823), are Leu823 and Val-824 in the GluN2C subunit. Both leucine and valine are
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hydrophobic amino acids and the side chains are larger than alanine. These
two amino acids may form a small hydrophobic environment near the
methionine position, which can significantly alter the alcohol molecule interacts
with the GluN2C (Met-821) position. We also found another five different amino
acids located near the C-terminal end of the M4 domain. However, the
difference in the physical and chemical properties among these amino acids is
not significant. So, it is unlikely those amino acids can cause long-term effects
on the alcohol modulation of the GluN2C (Met-821) position.

In the present studies, we showed that the Met-821 position involved in
regulating ethanol sensitivity and ion channel gating. We also showed Gly-638
and Met-821 positions in the M3-M4 intersubunit interfaces between GluN1 and
GluN2C subunits interactively regulate ethanol sensitivity. The results we
observed from GluN2C-containing NMDAR are different from the previous
discoveries in the NMDAR containing GluN2A subunit. The difference may
mainly lies in the sequence difference between GluN2A and GluN2C M4
domains and small hydrophobic environment formed near the methionine
position.
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Figure 1. The structural model of M domains of the NMDARs. Shown is
a model of the NMDA receptor M domains from [1]. M domains of the GluN1
subunit are shown in yellow, and those of the GluN2A subunit are shown
in green. Five alcohol sensitive positions are illustrated by CPK models.
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A

B

Figure 2. A methionine residue in the M4 domain is highly conserved in
all GluN subunit.A, shown is the sequences of the M4 domains of the GluN
subunits. The arrow shows the position of the conserved methionine. B, model
of the NMDA receptor M domains from [1]. Met-821 position is illustrated by
CPK model.
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Figure 3. Effects of ethanol on tryptophan mutations at the methionine
residue in the M4 domain of GluN2 subunits. A, concentration-response
curves for ethanol inhibition of glutamate-activated current in cells
expressing tryptophan mutations in GluN2 subunits. Data are the means ±
S.E. of n = 6–9 cells; error bars not visible were smaller than the size of the
symbols. Curves shown are the best fits to the equation given under
“Methods” B, graphs plot IC50 values for ethanol in tryptophan mutations in
GluN2 subunits. Asterisks indicate IC50 values that differed significantly from
that for wild type (***, p < 0.001; ANOVA followed by Tukey's test).
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Figure 4. Single mutations at Met-821 residue in the M4 domain of
GluN2C subunit can alter ethanol inhibition. A, records are currents
activated by 300 μM glutamate and 50 μM glycine in the absence and
presence of 100mM ethanol in cells expressing various mutant GluN2C
subunit. B, shown are concentration-response curves for ethanol inhibition
of glutamate-activated current in cells expressing various single site
substitution mutations in GluN2C. Data are the means ± S.E. of n = 6–9
cells; error bars not visible were smaller than the size of the symbols. Curves
shown are the best fits to the equation given under “Methods” C, graphs plot
IC50 values for ethanol in various single site substitution mutations in
GluN2C. Asterisks indicate IC50 values that differed significantly from that for
wild type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA
followed by Dunnett's test).
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Figure 5. Relation of amino acid physicochemical parameters of the
substituent at Met-821 to ethanol sensitivity.Graphs plot Log IC50 for
ethanol versus hydrophilicity (A), molecular volume in Å3 (B), polarity (C),
and LogP (D). The lines shown are the least-squares fits to the data. No
significant linear relations were obtained between log IC50 and
physicochemical parameters of the substituents.
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Figure 6. Triheteromeric GluN1/GluN2A/GluN2C M821G NMDAR Can
Restore Ion Channel Gating Function. Records are currents activated by
300 μM glutamate and 50 μM glycine in the absence and presence of
200nM Zn2+ in cells expressing diheteromeric or triheteromeric NMDARs.
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Figure 7. Single mutations at Met-821 residue in the M4 domain of
GluN2C subunit can alter the EC50 for peak and steady-state glutamateactivated current and apparent desensitization. A, records are currents
activated by 300 μM glutamate in the presence of 50 μM glycine in cells
expressing various mutant GluN2C subunit. B, concentration-response
curves for glutamate-activated current in cells expressing various single site
substitution mutations in GluN2C. Data are the means ± S.E. of n = 6–9
cells; error bars not visible were smaller than the size of the symbols. Curves
shown are the best fits to the equation given under “Methods” C, graphs plot
glutamate EC50 values in various single site substitution mutations in
GluN2C. D, bar graph shows the average values of maximal steady-state to
peak current ratio (Iss:Ip) in lifted cells coexpressing GluN1 and WT GluN2C
subunits or GluN2C subunits containing various mutations at M821.
Asterisks indicate EC50 values that differed significantly from that for wild
type GluN1/GluN2C subunits (*, p < 0.05 **, p < 0.01 ***, p < 0.001; ANOVA
followed by Dunnett's test).
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Figure 8. Relationship between glutamate EC50 and apparent
desensitization. A, the graph plots values of glutamate log EC50 for steadystate current versus values of glutamate log EC50 for peak current in the
series of mutants. Glutamate EC50 values for peak and steady-state current
were not statistically significantly correlated (R2 = 0.482; P > 0.05). The line
shown is the least-squares fit to the data. B-C, the graph plots the
maximal Iss:Ip versus peak (●) and steady-state (○) log EC50 values for
glutamate-activated current in various GluN2C(Met-821) mutant subunits.
Maximal Iss:Ip for glutamate was not correlated with steady-state glutamate
log EC50 (R2 = 0.092; P > 0.05) and peak glutamate log EC50 (R2 =
0.129; P > 0.05). The lines shown are the least squares fits to the data: peak
(solid line) and steady-state (dash line).
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Figure 9. The deactivation time constant (τ) of substituent at GluN2C
(Met-821). Bar graph shows the average values of deactivation time course
in the presence of 300 300 μM glutamate and 50 μM glycine.
Asterisks indicate Tau that differed significantly from that for wild type
GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA followed by
Dunnett's test).
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Figure 10. Single tryptophan mutations in the M3 and M4 domains of
GluN1 and GluN2C subunits can alter ethanol inhibition. A, records are
currents activated by 300 μM glutamate and 50 μM glycine in the absence
and presence of 100mM ethanol in cells expressing various mutants. B,
concentration-response curves for ethanol inhibition of glutamate-activated
current in cells expressing various single tryptophan substitution mutations.
Data are the means ± S.E. of n = 6–9 cells; error bars not visible were
smaller than the size of the symbols. Curves shown are the best fits to the
equation given under “Methods” C, graphs plot IC50 values for ethanol in
various single tryptophan substitution mutations. Asterisks indicate
IC50 values that differed significantly from that for wild type GluN1/GluN2C
subunits (*, p < 0.05 ***, p < 0.001; ANOVA followed by Dunnett's test).
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Figure 11. Cysteine mutations in the M3 and M4 domains of GluN1 and
GluN2C subunits can alter ethanol inhibition. A, records are currents
activated by 300 μM glutamate and 50 μM glycine in the absence and
presence of 100mM ethanol in cells expressing various cysteine mutations.
B, concentration-response curves for ethanol inhibition of glutamateactivated current in cells expressing various cysteine mutations. Data are
the means ± S.E. of n = 6–9 cells; error bars not visible were smaller than
the size of the symbols. Curves shown are the best fits to the equation given
under “Methods” C, graphs plot IC50 values for ethanol in various cysteine
mutations. Asterisks indicate IC50 values that differed significantly from that
for wild type GluN1/GluN2C subunits (***, p < 0.001; ANOVA followed by
Dunnett's test).

68

Figure 12. Positions in the GluN1 subunit M3 domain interact with
GluN2C (Met-821) in M4 domain to regulate NMDA receptor ethanol
sensitivity. A-D, graphs plot ethanol IC50 values versus the substituent at
position 638 or 639 in GluN1 for mutants at GluN2C position
821. Asterisks indicate significant interactions detected using logtransformed IC50 values (**, p < 0.01; ****, p < 0.0001; two-way ANOVA)
(left panel). Mutant cycle analysis of ethanol IC50 values for the subunit
combinations. Apparent free energy values associated with the various
mutations (ΔGX) are given in kcal mol−1. Asterisks indicate a statistically
significant difference of the apparent interaction energy ΔΔGINT from zero
energy determined using a one-sample t test (**, p < 0.01; ****, p < 0.0001)
(right panel).
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Figure 13. Cysteine mutations in the M3 and M4 domains of GluN1 and
GluN2C subunits can alter the EC50 for steady-state glutamateactivated current. A, records are currents activated by 300 μM glutamate
in the presence of 50 μM glycine in cells expressing various cysteine
mutations. B, concentration-response curves for glutamate-activated
current in cells expressing various cysteine mutations. Data are the means
± S.E. of n = 6–9 cells; error bars not visible were smaller than the size of
the symbols. Curves shown are the best fits to the equation given under
“Methods” C, graphs plot glutamate EC50 values in various cysteine
mutations. Asterisks indicate EC50 values that differed significantly from that
for wild type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA
followed by Dunnett's test).

70

Figure 14. The deactivation time constant (τ) of cysteine mutations in
the M3 and M4 domains of GluN1 and GluN2C subunits. Bar graph
shows the average values of deactivation time course in the presence of
300 300 μM glutamate and 50 μM glycine. Asterisks indicate Tau values
that differed significantly from that for wild type GluN1/GluN2C subunits
(**, p < 0.01 ***, p < 0.001; ANOVA followed by Dunnett's test).
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Figure 15. Positions in the GluN1 subunit M3 domain interact with
GluN2C (Met-821) in M4 domain to regulate NMDA receptor
deactivation time course. A-D, graphs plot deactivation time
constants versus the substituent at position 638 or 639 in GluN1 for
mutants at GluN2C position 821. Asterisks indicate significant interactions
(****, p < 0.0001; two-way ANOVA) (left panel). Mutant cycle analysis of
deactivation time constants for the subunit combinations. Apparent free
energy values associated with the various mutations (ΔGX) are given in kcal
mol−1. Asterisks indicate a statistically significant difference of the apparent
interaction energy ΔΔGINT from zero energy determined using a onesample t test (****, p < 0.0001) (right panel).
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Figure 16. Effects of DTT on cysteine mutations in the M3 and M4
domains of GluN1 and GluN2C subunits. Bar graph summary of the
percentage of change (mean± SEM) in 300 μM glutamate steady-state (Iss)
current amplitude after redox modification of wild type and cysteine
mutations with reducing agent DTT. The percentage of change in Iss after
DTT treatment is defined as [((Iafter/Iinital) − 1) × 100]. Negative values
represent a decrease in Iss after DTT reaction, whereas positive values
represent an increase in Iss. Asterisks indicate the percentage of change that
differed significantly from that for wild type GluN1/GluN2C subunits (**, p <
0.01; ANOVA followed by Dunnett's test).
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Figure 17. Effects of DTT on the deactivation time constant (τ) of
cysteine mutations in the M3 and M4 domains of GluN1 and GluN2C
subunits. Bar graph shows the average values of deactivation time course
before and after DTT treatment in the presence of 300 μM glutamate and 50
μM glycine. Asterisks indicate Tau that differed significantly from that for wild
type GluN1/GluN2C subunits (**, p < 0.01 ***, p < 0.001; ANOVA followed
by Bonferroni's test).
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Figure 18. Model of the MD of the NMDARs. Model of the MDs of the
GluN1/GluN2C subunit showing M3 and M4 helices (GluN1, yellow;
GluN2C, green). Other MDs have been removed for clarity. Space-filling
side groups are shown for the G638C and F639C positions in the M3 helices
of GluN1, M821C position in the M4 helices of GluN2C. Disulfide bridges
are represented by yellow dashed lines.
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Figure 19. Relation of agonist potency, ion channel gating to EtOH
sensitivity in NMDAR containing GluN2C (Met-821) mutant subunits. AC, graph plot log IC50 for EtOH vs log EC50 for glutamate peak and steadystate current and maximal Iss:Ip. Data points are labeled with the substituted
amino acid for the various mutants at GluN2C (Met-821). The lines shown
are the least squares fits to the data. No significant correlations were
obtained between log EtOH IC50 vs log Ip EC50 (R2 = 0.182; P > 0.05), log Iss
EC50 (R2 = 0.019; P > 0.05). A significant linear relation was obtained from
log EtOH IC50 vs maximal Iss:Ip (R2 = 0.501; P < 0.05).
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Figure 20. Model of the MD of the NMDARs. A, model of the MD of the
GluN2A subunit. Space-filling side groups are shown for the different amino
acid in the M3 and M4 domains compared to GluN2C subunit. GluN2A (Met823) residue is labeled by yellow. B, model of the MD of the GluN2C subunit.
Space-filling side groups are shown for the different positions in the M3 and
M4 domains compared to GluN2A subunit. GluN2C (Met-821) is labeled by
yellow.
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